Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature-Reference-Cited by-同舟云学术

Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature

Published:2011-06 Issue:8 Volume:10 Page:460-463
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Ingegnoli Francesca,Favalli Ennio Giulio,Meroni Pier Luigi

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference41 articles.

1. Rheumatoid arthritis;Lee;Lancet,2001

2. The role of TNF alpha and IL-1 in rheumatoid arthritis;Feldmann;Curr Dir Autoimmun,2001

3. Cytokine pathways and joint inflammation in rheumatoid arthritis;Choy;N Engl J Med,2001

4. Treatment of rheumatoid arthritis in the third millennium;Skapenko;Scand J Rheumatol,2001

5. Biological and clinical effects of anti-TNFalpha treatment;Valesini;Autoimmun Rev,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study;RMD Open;2023-03

2. Biologic discontinuation strategies and outcomes in patients with rheumatoid arthritis;Expert Review of Clinical Immunology;2019-11-10

3. Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects;Drugs;2019-09-04

4. Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis;Expert Opinion on Investigational Drugs;2019-06-17

5. Current perspective on rituximab in rheumatic diseases;Drug Design, Development and Therapy;2017-10